Does INTERFERON BETA-1B Cause Injection site atrophy? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Injection site atrophy have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 0.4% of all adverse event reports for INTERFERON BETA-1B.
44
Reports of Injection site atrophy with INTERFERON BETA-1B
0.4%
of all INTERFERON BETA-1B reports
0
Deaths
7
Hospitalizations
How Dangerous Is Injection site atrophy From INTERFERON BETA-1B?
Of the 44 reports, 7 (15.9%) required hospitalization, and 1 (2.3%) were considered life-threatening.
Is Injection site atrophy Listed in the Official Label?
Yes, Injection site atrophy is listed as a known adverse reaction in the official FDA drug label for INTERFERON BETA-1B.
What Other Side Effects Does INTERFERON BETA-1B Cause?
Multiple sclerosis relapse (1,229)
Influenza like illness (1,042)
Injection site pain (1,014)
Fatigue (783)
Drug ineffective (767)
Injection site erythema (724)
Injection site reaction (707)
Pain (597)
Headache (596)
Multiple sclerosis (589)
What Other Drugs Cause Injection site atrophy?
GLATIRAMER (282)
ASFOTASE ALFA (144)
TRIAMCINOLONE ACETONIDE (121)
INTERFERON BETA-1A (103)
TRIAMCINOLONE (34)
INSULIN GLARGINE-YFGN (27)
MEDROXYPROGESTERONE (22)
INSULIN GLARGINE (17)
SOMATROPIN (17)
INSULIN LISPRO (15)
Which INTERFERON BETA-1B Alternatives Have Lower Injection site atrophy Risk?
INTERFERON BETA-1B vs INTERFERON GAMMA
INTERFERON BETA-1B vs INTERFERON GAMMA-1B
INTERFERON BETA-1B vs INVEGA
INTERFERON BETA-1B vs INVEGA SUSTENNA
INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS